Results 161 to 170 of about 296,701 (305)

Comparative efficacy of drug-eluting balloon and drug-eluting stent for treatment of in-stent restenosis: a systematic review and meta-analysis

open access: yesJournal of the Pakistan Medical Association
Objective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest ...
Tinanda Tarigan   +3 more
doaj   +1 more source

Identification of Hemodynamically Optimal Coronary Stent Designs Based on Vessel Caliber [PDF]

open access: yes, 2012
Coronary stent design influences local patterns of wall shear stress (WSS) that are associated with neointimal growth, restenosis, and the endothelialization of stent struts.
Gundert, Timothy J   +4 more
core   +1 more source

Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.

open access: yesJournal of the American College of Cardiology, 2020
D. Giacoppo   +21 more
semanticscholar   +1 more source

Behavior of restenosis after distal unprotected bifurcation left main coronary artery stenting [PDF]

open access: diamond, 2022
Ezz-eldein El-sawy   +3 more
openalex   +1 more source

Degraded products generated by iron stent inhibit the vascular smooth muscle cell proliferation by downregulating AP-1

open access: yesJournal of Materials Science: Materials in Medicine
In-stent restenosis (ISR) following interventional therapy is a fatal clinical complication. Current evidence indicates that neointimal hyperplasia driven by uncontrolled proliferation of vascular smooth muscle cells (VSMC) is a major cause of restenosis.
Jiabing Huang   +4 more
doaj   +1 more source

Efficacy of Drug-Eluting Stents for Treating In-Stent Restenosis of Drug-Eluting Stents (from the Korean DES ISR Multicenter Registry Study [KISS]) [PDF]

open access: bronze, 2011
Young‐Guk Ko   +12 more
openalex   +1 more source

Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis

open access: yes
Clinical Cardiology, Volume 49, Issue 2, February 2026.
Saleha Khattak   +2 more
wiley   +1 more source

In-stent restenosis.

open access: yesCardiovascular therapeutics, 2011
The introduction of coronary stents marked a major turning point in the practice of interventional cardiology. Whereas the efficacy of balloon angioplasty was challenged both by immediate mechanical complications and by a high incidence of restenosis, coronary stents offered cardiologists a means by which to not only augment immediate procedural ...
Michael S, Kim, Larry S, Dean
openaire   +1 more source

Characterisation of the mechanobiology of stents in vitro [PDF]

open access: yes, 2014
This paper was presented at the 4th Micro and Nano Flows Conference (MNF2014), which was held at University College, London, UK. The conference was organised by Brunel University and supported by the Italian Union of Thermofluiddynamics, IPEM, the ...
4th Micro and Nano Flows Conference (MNF2014)   +6 more
core  

Home - About - Disclaimer - Privacy